Revance Therapeutics, Inc.

The current price of RVNC is 3.29 USD — it has decreased by 7.84% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Revance Therapeutics, Inc. stocks are traded under the ticker RVNC.

Revance Therapeutics, Inc. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.

RVNC stock is 10.53% volatile and has beta coefficient of 1.93. Check out the list of the most volatile stocks — is Revance Therapeutics, Inc. there?

RVNC earnings for the last quarter are −0.39 USD per share, whereas the estimation was −0.69 USD resulting in a 44.16% surprise. The estimated earnings for the next quarter are −0.65 USD per share. See more details about Revance Therapeutics, Inc. earnings.

Revance Therapeutics, Inc. revenue for the last quarter amounts to ‪56.78 M‬ USD despite the estimated figure of ‪58.40 M‬ USD. In the next quarter revenue is expected to reach ‪62.12 M‬ USD.

Yes, you can track Revance Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.

RVNC stock has fallen by 12.27% compared to the previous week, the month change is a 30.00% fall, over the last year Revance Therapeutics, Inc. has showed a 89.61% decrease.

Today Revance Therapeutics, Inc. has the market capitalization of ‪372.05 M‬, it has decreased by 4.46% over the last week.

No, RVNC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, RVNC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Revance Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.

RVNC reached its all-time high on Nov 11, 2015 with the price of 42.41 USD, and its all-time low was 3.63 USD and was reached on Apr 18, 2024.
See other stocks reaching their highest and lowest prices.

As of Apr 25, 2024, the company has 597.00 employees. See our rating of the largest employees — is Revance Therapeutics, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Revance Therapeutics, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Revance Therapeutics, Inc. stock shows the sell signal. See more of Revance Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Revance Therapeutics, Inc. future price: according to them, RVNC price has a max estimate of 30.00 USD and a min estimate of 6.00 USD. Read a more detailed Revance Therapeutics, Inc. forecast: see what analysts think of Revance Therapeutics, Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Revance Therapeutics, Inc. EBITDA is ‪−207.03 M‬ USD, and current EBITDA margin is −88.46%. See more stats in Revance Therapeutics, Inc. financial statements.